title: Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex.
abstract: In the recent clinical trials of teicoplanin therapy of endocarditis caused by Staphylococcus aureus, at least one instance of the emergence of teicoplanin-resistant strains during therapy has been reported (G.W. Kaatz, S. M. Seo, N. J. Dorman, and S. A. Lerner, J. Infect. Dis 162:103-108, 1990). We have confirmed, using conventional electrophoresis of EcoRI-digested chromosomal DNA and pulsed-field gel electrophoresis of SmaI-digested chromosomal DNA, that the resistant strain (12873) (MIC, 16 micrograms/ml) is genetically very similar to the susceptible parent (12871) (MIC, 4 micrograms/ml). Kaatz et al. were able to select spontaneous teicoplanin-resistant mutants (10(-9)), suggesting that a single gene might be involved. We have shown that the mutation is highly stable during growth in the absence of teicoplanin. Using Tn551, we have selected insertion mutants of 12873 that become teicoplanin susceptible. We have examined a number of aspects of cell wall physiology in strains 12871 and 12873 and the teicoplanin-susceptible Tn551 mutants of 12873. 12873 was more susceptible to lysostaphin lysis than 12871 and the susceptible Tn551 derivatives of 12873. Autolysis in phosphate buffer (pH 7.5) and cell wall turnover rates were similar in 12871 and 12873. An analysis of membrane proteins revealed the expression of a ca. 35-kDa protein and increased expression of both polypeptides of penicillin-binding protein (PBP) 2 (PBP2) in 12873 relative to 12871 and the Tn551 mutants of 12873. This increased expression was not related to PBP2', since both strains were susceptible to oxacillin in 2% NaCl (MIC, < or = 0.25 microgram/ml) and cellular DNA from neither strain hybridized with a specific mec gene probe. Two independent Tn551 inserts have been mapped to a ca. 117-kb SmaI fragment of the chromosome. These data suggest the possibility that the mutation resulting in resistance to teicoplanin involves the regulation of expression of both polypeptides of PBP2 and a 35-kDa membrane protein.
authors.affiliation: Research Service, Department of Veterans Affairs Medical Center, Cleveland, Ohio.
authors.forename: D M
authors.initials: DM
authors.lastname: Shlaes
authors.forename: J H
authors.initials: JH
authors.lastname: Shlaes
authors.forename: S
authors.initials: S
authors.lastname: Vincent
authors.forename: L
authors.initials: L
authors.lastname: Etter
authors.forename: P D
authors.initials: PD
authors.lastname: Fey
authors.forename: R V
authors.initials: RV
authors.lastname: Goering
mesh_terms: D001329:Autolysis; D001426:Bacterial Proteins / Q000096:biosynthesis*; D002352:Carrier Proteins; D002439:Cefotaxime / Q000494:pharmacology; D002473:Cell Wall / Q000378:metabolism; D002876:Chromosomes, Bacterial / Q000378:metabolism; D015342:DNA Probes; D004269:DNA, Bacterial / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D006602:Hexosyltransferases / Q000096:biosynthesis*; D008248:Lysostaphin / Q000494:pharmacology; D008565:Membrane Proteins / Q000096:biosynthesis*; D009097:Multienzyme Complexes / Q000096:biosynthesis*; D002267:Muramoylpentapeptide Carboxypeptidase; D016296:Mutagenesis; D009693:Nucleic Acid Hybridization; D046915:Penicillin-Binding Proteins; D010458:Peptidyl Transferases / Q000096:biosynthesis*; D010957:Plasmids; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism*; D017334:Teicoplanin / Q000494:pharmacology*
chemical_list: D001426:Bacterial Proteins; D002352:Carrier Proteins; D015342:DNA Probes; D004269:DNA, Bacterial; D008565:Membrane Proteins; D009097:Multienzyme Complexes; D046915:Penicillin-Binding Proteins; D017334:Teicoplanin; D010458:Peptidyl Transferases; D006602:Hexosyltransferases; D002267:Muramoylpentapeptide Carboxypeptidase; D008248:Lysostaphin; D002439:Cefotaxime